Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) EBT (2014 - 2026)

Viking Therapeutics' (VKTX) quarterly EBT came in at -$128.1 million in Q2 2026, down 95.38% year-over-year from -$2.8 billion in Q2 2025, and up 19.12% quarter-over-quarter from -$158.3 million in Q1 2026.

Analysis

Viking Therapeutics (VKTX) EBT (2014 - 2026) Analysis & Trends

Viking Therapeutics has disclosed EBT across 13 years of filings, most recently posting -$128.1 million for Q2 2026.

  • In Q2 2026, EBT fell 95.38% year-over-year to -$128.1 million; the TTM figure through Jun 2026 stood at -$534.9 million (down 211.76% YoY), while the FY2025 annual figure was -$359.6 million, down 227.0% from the prior year.
  • EBT came in at -$128.1 million for Q2 2026 at Viking Therapeutics, up from -$158.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$15.7 million in Q3 2022 to a low of -$158.3 million in Q1 2026.
  • Average EBT over 5 years is -$50.6 million, with a median of -$24.8 million recorded in 2023.
  • Year-over-year, EBT fell 10.44% in 2023 and slumped 345.56% in 2025.
  • Over 5 years, EBT stood at -$19.6 million in 2022, then fell by 25.72% to -$24.6 million in 2023, then tumbled by 44.0% to -$35.4 million in 2024, then sank by 345.56% to -$157.7 million in 2025, then grew by 18.8% to -$128.1 million in 2026.
  • Per Business Quant data, the three most recent EBT figures were -$128.1 million in Q2 2026, -$158.3 million in Q1 2026, and -$157.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 6.75 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 4.28 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.80 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.25 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.39 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -128.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -128.05 Mn
Mar 31, 2026 -158.33 Mn
Dec 31, 2025 -157.70 Mn
Sep 30, 2025 -90.79 Mn
Jun 30, 2025 -65.54 Mn
Mar 31, 2025 -45.61 Mn
Dec 31, 2024 -35.39 Mn
Sep 30, 2024 -25.03 Mn
Jun 30, 2024 -22.23 Mn
Mar 31, 2024 -27.33 Mn
Dec 31, 2023 -24.58 Mn
Sep 30, 2023 -22.53 Mn
Jun 30, 2023 -19.19 Mn
Mar 31, 2023 -19.50 Mn
Dec 31, 2022 -19.55 Mn
Sep 30, 2022 -15.75 Mn
Jun 30, 2022 -17.38 Mn
Mar 31, 2022 -17.14 Mn
Dec 31, 2021 -12.35 Mn
Sep 30, 2021 -13.28 Mn
API Access

Viking Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=VKTX&period=max&api_key=YOUR_API_KEY